134 related articles for article (PubMed ID: 24949303)
1. Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma.
Mohammadizadeh F; Sajadieh S; Sajjadieh H; Kasaei Z
Adv Biomed Res; 2014; 3():132. PubMed ID: 24949303
[TBL] [Abstract][Full Text] [Related]
2. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
4. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
5. Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
Qi JP; Yang YL; Zhu H; Wang J; Jia Y; Liu N; Song YJ; Zan LK; Zhang X; Zhou M; Gu YH; Liu T; Hicks DG; Tang P
Breast Cancer (Auckl); 2012; 6():1-8. PubMed ID: 22259247
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Androgen Receptor in Invasive Breast Cancer and Its Association with Clinicopathologic Features in East Azarbaijan Province of Iran: A Cross-Sectional Study.
Nikanfar A; Nikanfar M; Fakhrjou A
Int J Hematol Oncol Stem Cell Res; 2023 Jul; 17(3):186-193. PubMed ID: 37817975
[No Abstract] [Full Text] [Related]
7. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.
Micello D; Marando A; Sahnane N; Riva C; Capella C; Sessa F
Virchows Arch; 2010 Oct; 457(4):467-76. PubMed ID: 20809337
[TBL] [Abstract][Full Text] [Related]
8. [Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status].
Chen J; Zhang X; Tian R; Liu Y; Dong HM; Guo RF; Liang HY
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):743-6. PubMed ID: 21215164
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?
Safarpour D; Pakneshan S; Tavassoli FA
Am J Cancer Res; 2014; 4(4):353-68. PubMed ID: 25057438
[TBL] [Abstract][Full Text] [Related]
10. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
[TBL] [Abstract][Full Text] [Related]
11. Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India.
Sidhu S; Kwatra KS; Kinsley PA
South Asian J Cancer; 2023 Oct; 12(4):319-325. PubMed ID: 38130277
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women.
Badowska-Kozakiewicz AM; Sobol M; Patera J; Kozłowski W
Arch Med Sci; 2013 Jun; 9(3):466-71. PubMed ID: 23847668
[TBL] [Abstract][Full Text] [Related]
13. Expression of androgen receptors in primary breast cancer.
Park S; Koo J; Park HS; Kim JH; Choi SY; Lee JH; Park BW; Lee KS
Ann Oncol; 2010 Mar; 21(3):488-492. PubMed ID: 19887463
[TBL] [Abstract][Full Text] [Related]
14. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
15. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
Dubrava AL; Kyaw PSP; Newman J; Pringle J; Westhuyzen J; La Hera Fuentes G; Shakespeare TP; Sakalkale R; Aherne NJ
Breast Cancer (Dove Med Press); 2023; 15():359-371. PubMed ID: 37197610
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in triple negative breast carcinoma and its association with the clinicopathological parameters.
Teoh PY; Tan GC; Mahsin H; Wong YP
Malays J Pathol; 2019 Aug; 41(2):125-132. PubMed ID: 31427547
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
18. Association of Epstein-Barr virus with invasive breast carcinoma and its impact on well-known clinicopathologic parameters in Iranian women.
Mohammadizadeh F; Zarean M; Abbasi M
Adv Biomed Res; 2014; 3():141. PubMed ID: 25161988
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
[TBL] [Abstract][Full Text] [Related]
20. Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):550-5. PubMed ID: 26230371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
